Additional Information
Market: OTCBB
Sector: Agribusiness
EPIC: CKGT
1 year chart
1 day chart
China Kangtai Cactus Bio-Tech
www.biocactus.com

China Kangtai Cactus Bio-Tech Inc. (China Kangtai) is principally engaged in the production, research and development, sales and marketing of products derived from cacti.

 

China Kangtai to launch patented cactus-based cigarettes in 2009

2nd Sep 2009, 1:33 pm
China Kangtai to launch patented cactus-based cigarettes in 2009

China Kangtai Cactus Biotech Inc (OTCBB: CKGT) announced plans to launch low nicotine and zero nicotine cigarettes based on cacti in the fourth quarter of 2009, following the successful completion of trial production.

The Nevada-based and China-focused group grows, develops, produces, and markets cactus-derived products including nutraceuticals, nutritious food, health and energy drinks, beer, wine and liquor, extracts and powders, and animal feed.

The new patented cactus cigarettes, under the registered trademark "Shengcao", are expected to increase sales by approximately US$220,000 in the fourth quarter, the group said in a statement.

The low nicotine cigarette is made from cactus, honeysuckle, ginkgo biloba leaves and a small amount of tobacco leaves. This cactus-derived cigarette lowers tar and nicotine content by 70 percent. The zero nicotine cigarette is made without any tobacco leaves.

China Kangtai CEO Jinjiang Wang said: "The cactus cigarette market shows huge potential for growth in China. China has about 390 million smokers, accounting for 30 percent of global smokers.”

China Kangtai controls over 387 acres of plants and maintains an active R&D group that holds 18 product patents and is seeking another 12. China Kangtai's products are sold throughout China via a distribution network that covers 12 of China's 23 provinces and two of China's four municipalities.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.